Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giovanni Sellitto, Alessia Morelli, Susanna Bassano, Antonella Conte, Viola Baione, Giovanni Galeoto & Anna Berardi. (2021) Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 625-646.
Read now
Read now
Astrid Karnoe, Lise M. Pedersen, Sashia Karlsen, Finn Boesen, Lasse Skovgaard & Lars Kayser. (2020) How people with multiple sclerosis experience the influence of nutrition and lifestyle factors on the disease. Disability and Rehabilitation 42:24, pages 3504-3515.
Read now
Read now
Articles from other publishers (29)
Ilya KisterCheongeun Oh, Elizabeth A. Douglas, Tamar E. Bacon, Isabella L. O'Shea, Erica H. Parrotta, Andrew Bouley, Ellen LathiJoshua Katz. (2023) No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis. Neurology Clinical Practice 13:5.
Crossref
Crossref
Helga Taylor, Saleh Alhasan, Maha Saleem, Shane Poole, Fei Jiang, Erin E Longbrake & Riley Bove. (2023) Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: A pilot study. Multiple Sclerosis and Related Disorders 77, pages 104864.
Crossref
Crossref
John R Corboy, Robert J Fox, Ilya Kister, Gary R Cutter, Charity J Morgan, Rebecca Seale, Eric Engebretson, Tarah Gustafson, Aaron E Miller, Dennis Bourdette, Vijayshree Yadav, Andrew Goodman, Michael Racke, Robert Fallis, Carlo Tornatore, Myla Goldman, Meena Kannan, Subramaniam Sriram, Joseph Berger, Anne Cross, Kottil Rammohan, Zongqi Xia, Thomas Leist, Sharon Lynch, Eric Klawiter, Lilyana Amezcua & James Bowen. (2023) Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial. The Lancet Neurology 22:7, pages 568-577.
Crossref
Crossref
Alexandra (Sasha) Cook & Alexander Zill. (2023) Individual health status as a resource: Analyzing associations between perceived illness symptom severity, burnout, and work engagement among employees with autoimmune diseases. Applied Psychology.
Crossref
Crossref
Jeffrey L. Bennett, Kazuo Fujihara, Ho Jin Kim, Romain Marignier, Kevin C. O'Connor, Robert C. Sergott, Anthony Traboulsee, Heinz Wiendl, Jens Wuerfel, Scott S. Zamvil, Veronica G. Anania, Regine Buffels, Thomas Künzel, Annemarie N. Lekkerkerker, Siân Lennon-Chrimes & Sean J. Pittock. (2023) SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Frontiers in Neurology 14.
Crossref
Crossref
Ruth Ann Marrie, Caitlin McFadyen, Lauren Yaeger & Amber Salter. (2023) A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale. International Journal of MS Care 25:1, pages 20-25.
Crossref
Crossref
Gustavo Saposnik, Sanketh Andhavarapu, Susana Sainz de la Maza, Tamara Castillo-Triviño, Mónica Borges, Beatriz Pardiñas Barón, Javier Sotoca, Ana Alonso, Ana B Caminero, Laura Borrega, José L Sánchez-Menoyo, Francisco J Barrero-Hernández, Carmen Calles, Luis Brieva, María R Blasco, Julio Dotor García-Soto, María del Campo-Amigo, Laura Navarro-Cantó, Eduardo Agüera, Moisés Garcés, Olga Carmona, Laura Gabaldón-Torres, Lucía Forero, Mariona Hervás, Elena García-Arcelay, María Terzaghi, Rocío Gómez-Ballesteros & Jorge Maurino. (2022) Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis. Multiple Sclerosis and Related Disorders 68, pages 104138.
Crossref
Crossref
José E. Meca-Lallana, Rocío Gómez-Ballesteros, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L. Martínez-Ginés, Inés González-Suárez, Sabas Boyero, Lucía Romero-Pinel, Ángel P. Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi & Jorge Maurino. (2022) Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study. Neurology and Therapy 11:3, pages 1101-1116.
Crossref
Crossref
Tamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, Jesús Martín-Martínez, Javier Sotoca, Ana Alonso, Ana B. Caminero, Laura Borrega, José L. Sánchez-Menoyo, Francisco J. Barrero-Hernández, Carmen Calles, Luis Brieva, María R. Blasco-Quílez, Julio Dotor García-Soto, María del Campo-Amigo, Laura Navarro-Cantó, Eduardo Agüera, Moisés Garcés-Redondo, Olga Carmona, Laura Gabaldón-Torres, Lucía Forero, Mariona Hervás, Jorge Mauriño & Susana Sainz de la Maza. (2022) Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 64, pages 103969.
Crossref
Crossref
Ruth Ann MarrieLeanne Kosowan, Gary CutterRobert Fox & Amber Salter. (2022) Disparities in Telehealth Care in Multiple Sclerosis. Neurology Clinical Practice 12:3, pages 223-233.
Crossref
Crossref
Elisabet Lopez-Soley, Jose E. Meca-Lallana, Sara Llufriu, Yolanda Blanco, Rocío Gómez-Ballesteros, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, Carmen Calles, María L. Martinez-Gines, Inés Gonzalez-Suarez, Sabas Boyero, Lucía Romero-Pinel, Ángel P. Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Maria Sepulveda & Elisabeth Solana. (2022) Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder. Journal of Personalized Medicine 12:5, pages 743.
Crossref
Crossref
Riley Bove, Annika Anderson, William Rowles, Kelsey A. Rankin, Nancy K. Hills, Mia Carleton, Joanna Cooper, Bruce A.C. Cree, Jeffrey M. Gelfand, Jennifer S. Graves, Roland G. Henry, Kristen M Krysko, Gillian Rush, Scott S. Zamvil, Hadine Joffe, Jonah R. Chan & Ari J. Green. (2022) A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial. Multiple Sclerosis and Related Disorders 61, pages 103747.
Crossref
Crossref
Ruth Ann Marrie, Casandra Dolovich, Gary R Cutter, Robert J. Fox & Amber Salter. (2022) Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical 8:2, pages 205521732211020.
Crossref
Crossref
Susana Sainz de la Maza, Jorge Maurino, Mónica Borges, Jesús Martín-Martínez, Javier Sotoca, Ana Alonso, Ana B Caminero, Laura Borrega, José L Sánchez-Menoyo, Francisco J Barrero-Hernández, Carmen Calles, Luis Brieva, Maria R Blasco, Julio Dotor García-Soto, María del Campo-Amigo, Laura Navarro-Cantó, Eduardo Agüera, Moisés Garcés, Olga Carmona, Laura Gabaldón-Torres, Lucía Forero, Mariona Hervás, Lucía Ruiz de Alda, Rocío Gómez-Ballesteros & Tamara Castillo-Triviño. (2022) Measuring productivity loss in early relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 58, pages 103398.
Crossref
Crossref
Ruth Ann Marrie, Casandra Dolovich, Gary R. Cutter, Robert J. Fox & Amber Salter. (2021) Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Wim Van Hecke, Lars Costers, Annabel Descamps, Annemie Ribbens, Guy Nagels, Dirk Smeets & Diana M. Sima. (2021) A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis. Brain Sciences 11:9, pages 1171.
Crossref
Crossref
Ilya Kister, Tamar Bacon & Gary R. Cutter. (2021) How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity. Neurology Clinical Practice 11:4, pages 335-341.
Crossref
Crossref
Ruth Ann MarrieLeanne KosowanGary R. CutterRobert FoxAmber Salter. (2021) Uptake and Attitudes About Immunizations in People With Multiple Sclerosis. Neurology Clinical Practice 11:4, pages 327-334.
Crossref
Crossref
José E. Meca-Lallana, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L. Martínez-Ginés, Inés González-Suárez, Sabas Boyero, Lucía Romero-Pinel, Ángel P. Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi, Rocío Gómez-Ballesteros & Javier Ballesteros. (2021) Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLOS ONE 16:7, pages e0255317.
Crossref
Crossref
Mehmet Özkeskin, Fatih Özden, Serkan Bakırhan & Nur Yüceyar. (2021) Cross-cultural adaptation, reliability, and validity of the Turkish version of the SymptoMScreen. Multiple Sclerosis and Related Disorders 50, pages 102803.
Crossref
Crossref
Jorge Maurino, Javier Sotoca, Ángel P. Sempere, Luis Brieva, Carlos López de Silanes, Ana B. Caminero, María Terzaghi, Julia Gracia-Gil & Gustavo Saposnik. (2020) High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions. The Patient - Patient-Centered Outcomes Research 14:2, pages 241-248.
Crossref
Crossref
Ilya Kister, Tamar Bacon & Gary R. Cutter. (2020) A longitudinal study of symptom botheration in Multiple Sclerosis.. Multiple Sclerosis and Related Disorders 46, pages 102585.
Crossref
Crossref
Abbey J. Hughes, Krina Patel, Kathryn C. Fitzgerald, Aeysha Brown, Elizabeth S. Gromisch & Ellen M. Mowry. (2020) Reliability and validity of the multiple sclerosis resiliency scale (MSRS). Journal of the Neurological Sciences 418, pages 116983.
Crossref
Crossref
Gustavo Saposnik, Javier Sotoca, Ángel P. Sempere, Antonio Candeliere-Merlicco, Paola Díaz-Abós, Philippe N. Tobler, María Terzaghi & Jorge Maurino. (2020) Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?. Multiple Sclerosis and Related Disorders 45, pages 102354.
Crossref
Crossref
José Meca-Lallana, Jorge Maurino, Miguel Ángel Hernández-Pérez, Ángel P. Sempere, Luis Brieva, Elena García-Arcelay, María Terzaghi, Gustavo Saposnik & Javier Ballesteros. (2020) Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective. Neurology and Therapy 9:1, pages 173-179.
Crossref
Crossref
Yan Zhang, Bruce V Taylor, Steve SimpsonJr.Jr., Leigh Blizzard, Andrew J Palmer & Ingrid van der Mei. (2020) Validation of 0–10 MS symptom scores in the Australian multiple sclerosis longitudinal study. Multiple Sclerosis and Related Disorders 39, pages 101895.
Crossref
Crossref
Elisabetta Groppo, Alessio Signori, Maria Pia Sormani, Cristina Grosso, Loredana La Mantia, Davide Cattaneo & Marco Rovaris. (2019) Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre study. Multiple Sclerosis Journal - Experimental, Translational and Clinical 5:2, pages 205521731984367.
Crossref
Crossref
Kathryn C. Fitzgerald, Amber Salter, Tuula Tyry, Robert J. Fox, Gary Cutter, Ellen M. Mowry & Ruth Ann Marrie. (2019) Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes. Multiple Sclerosis and Related Disorders 29, pages 86-93.
Crossref
Crossref
Rivka Green, Gary Cutter, Michael Friendly & Ilya Kister. (2017) Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?. Multiple Sclerosis Journal - Experimental, Translational and Clinical 3:3, pages 205521731772830.
Crossref
Crossref